Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus
Clinical trial NCT02589639 · COMPLETED
Trial details
- NCT number
- NCT02589639
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-28
- Primary completion
- 2017-04-18
- Enrollment
- 269
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.